BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 4359681)

  • 21. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation and reversion of the Sabin vaccine strains of poliovirus.
    Minor PD
    Dev Biol Stand; 1993; 78():17-26. PubMed ID: 8388828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New approaches to poliovirus diagnosis using laboratory techniques: memorandum from a WHO meeting.
    Bull World Health Organ; 1992; 70(1):27-33. PubMed ID: 1348972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratypic differentiation of poliovirus strains of type I from pre- and post-vaccination groups.
    Sevani HK; Gharpure PV
    Indian J Med Res; 1969 Sep; 57(9):1591-606. PubMed ID: 4313048
    [No Abstract]   [Full Text] [Related]  

  • 25. Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):23-30. PubMed ID: 16290028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Sabin live poliovirus vaccine in Japan. 3. Studies on the method of administration of Sabin vaccine for babies.
    Kono R
    Jpn J Med Sci Biol; 1967 Apr; 20(2):151-66. PubMed ID: 4293412
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevalence of vaccine-derived polioviruses in sewage and river water in South Africa.
    Pavlov DN; Van Zyl WB; Van Heerden J; Grabow WO; Ehlers MM
    Water Res; 2005 Sep; 39(14):3309-19. PubMed ID: 15996707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Problems of live virus vaccine-associated poliomyelitis a paralytic case with isolation of all three poliovirus types.
    Mertens T; Schürmann W; Kruppenbacher J; Rheingans K; Kellermann K; Maass G; Eggers HJ
    Med Microbiol Immunol; 1983; 172(1):13-21. PubMed ID: 6308406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vaccination against poliomyelitis].
    Cellesi C; Rossolini A
    Pediatr Med Chir; 1984; 6(1):13-5. PubMed ID: 6099548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.
    Rahimi P; Tabatabaie H; Gouya MM; Zahraie M; Mahmudi M; Ziaie A; Rad KS; Shahmahmudi Sh; Musavi T; Azad TM; Nategh R
    J Clin Virol; 2007 Aug; 39(4):304-7. PubMed ID: 17590391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poliomyelitis: epidemiology and prophylaxis. 4. Serological and virological surveys conducted after a mass vaccination campaign for the control of a threatening poliomyelitis epidemic.
    Metselaar D; McDonald K; Gemert W; Nottay B; Muli JM
    Bull World Health Organ; 1977; 55(6):747-53. PubMed ID: 202417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of elution marker for the intratypic characterization of poliovirus strains.
    Szöllõsy E; Mucsi I; Pálmai M
    Acta Microbiol Acad Sci Hung; 1976; 23(4):301-8. PubMed ID: 193364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralization epitope patterns of poliovirus strains isolated from paralytic cases.
    Crainic R; Blondel B; Aubert-Combiescu A; Beytout D; Couillin P; Candrea A; Boué A; Horaud F
    Dev Biol Stand; 1984; 57():165-70. PubMed ID: 6084607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z
    Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy.
    Băicuş A; Persu A; Popescu M; Penciu A; Stavri S; Soare A; Grecu N; Szmal C; Oprişan G
    Roum Arch Microbiol Immunol; 2009; 68(3):145-50. PubMed ID: 20361534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
    Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
    Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of molecular and antigenic characterization for intratypic differentiation (ITD) of poliovirus strains.
    Adedeji AO; Okonko IO; Adu FD
    J Med Virol; 2012 Dec; 84(12):1975-9. PubMed ID: 23080505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.
    Khetsuriani N; Prevots DR; Quick L; Elder ME; Pallansch M; Kew O; Sutter RW
    J Infect Dis; 2003 Dec; 188(12):1845-52. PubMed ID: 14673763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of wild poliovirus circulation among healthy children in a rural area with high oral poliovirus vaccination coverage.
    Deshpande JM; Rao VK; Karnataki MV; Nadkarni SS; Saxena VK; Karambelkar RR; Ramdasi SG; Patil KS; Rodrigues JJ
    Indian J Med Res; 1996 Jun; 103():289-93. PubMed ID: 8707367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.